Digital Technology for Diabetes | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Norbert Freinkel emphasized the need for “more aggressive therapy with exogenous insulin”
during type 1 diabetes (T1D) pregnancy. Recent advances in diabetes technology …

Introduction: Recent high-profile calls have emphasized that women's experiences should
be considered in maternity care provisioning. We explored women's experiences of using …

Background Advanced hybrid closed loop (AHCL) therapy can improve glycaemic control in
pregnant women with type 1 diabetes. However, data are needed on the efficacy and safety …

Before the discovery of insulin and diet restriction, the Joslin Clinic reported very high
mortality rates for type 1 diabetes (T1D) that ranged from 824 per 1000 individuals aged 10 …

Aim To assess the efficacy of artificial pancreas systems (APS) use among pregnant women
with type 1 diabetes mellitus (T1DM) by conducting a meta‐analysis. Methods We searched …

Digital health technologies are being utilized increasingly in the modern management of
diabetes. These include tools such as continuous glucose monitoring systems, connected …

Aims: To compare glycemic control and maternal–fetal outcomes of women with type 1
diabetes (T1D) using hybrid closed loop (HCL) versus multiple daily insulin injections (MDI) …

One hundred years after the Nobel prize was bestowed on Banting and McLeod for the
'discovery'of insulin, we are again seeing major evolutions in the management of type 1 …

Aims The study objective was to compare daily glycemic profiles throughout gestation
between the mothers of large-for-gestational-age (LGA) and non-LGA newborns in patients …